Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of obesity ...

An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...

Transplanting insulin-producing cells along with engineered blood-vessel-forming cells has successfully reversed type 1 ...

Researchers at The University of Colorado Anschutz Medical Campus and colleagues at Massachusetts General Hospital, have ...

More than 830 million people worldwide have diabetes—a chronic, debilitating disease. But experts say it’s possible to ...

Why African American communities are more at risk for diabetes and how to manage it.

Type 1 diabetics have a lower risk of experiencing a cardiovascular event such as a stroke or heart attack than type 2 ...

Diabetes and obesity have become pressing health issues worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications widely used in the treatment of type 2 diabetes (T2D), have ...

A new awareness campaign from Abbott highlights a major sticking point in diabetes management: the harmful impact of societal ...

Sotagliflozin significantly reduces heart attacks and strokes in high-risk patients with diabetes and kidney disease, ...